Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genotype-phenotype correlations in phenylketonuria

F K Trefz1, P Burgard, T König

  • 1University of Heidelberg, Department of Pediatrics, Germany.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|July 30, 1993
PubMed
Summary

Genotyping phenylalanine hydroxylase (PAH) deficiency patients reveals predicted residual activity (PRA) correlates with newborn phenylalanine levels and intellectual outcome. Higher PRA indicates better outcomes in phenylketonuria (PKU) management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double superior vena cava and left brachiocephalic vein agenesis: a rare systemic vein anomaly and potential source of cardiac implantable electronic device and central venous catheter placement complications.

Folia morphologica·2021
Same author

Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate.

Molecular psychiatry·2004
Same author

Calculation of the resistance to CSF outflow.

Journal of neurology, neurosurgery, and psychiatry·2003
Same author

Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus.

The British journal of dermatology·2003
Same author

Gene structure of human carbamylphosphate synthetase 1 and novel mutations in patients with neonatal onset.

Human mutation·2003
Same author

[Diagnosis and follow-up in glaucoma patients using the Heidelberg retina tomograph].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2003

Area of Science:

  • Genetics
  • Biochemistry
  • Pediatrics

Background:

  • Phenylketonuria (PKU) is a metabolic disorder caused by phenylalanine hydroxylase (PAH) deficiency.
  • Genotyping offers a novel approach to characterize PAH deficiency.
  • Understanding genotype-phenotype correlations is crucial for managing PKU and preventing brain damage.

Purpose of the Study:

  • To investigate the utility of genotyping in the differential diagnosis of PAH deficiency.
  • To assess genotyping as a predictor of brain damage risk in well-treated PKU patients.
  • To correlate predicted residual activity (PRA) with newborn phenylalanine levels and intellectual outcomes.

Main Methods:

  • Genotyping of the PAH gene to determine mutation analysis and estimate PRA.
  • Longitudinal follow-up of 33 PKU patients over 9 years.

Related Experiment Videos

  • Measurement of plasma phenylalanine (phe) levels in newborns and intellectual outcome (IQ) at age 9.
  • Correlation of PRA with clinical data, categorizing patients into groups based on PRA levels (0%, 5-15%, ≥25%).

    • Main Results:

    • Significant differences in mean newborn plasma phenylalanine levels were observed between patients with low PRA (groups Ia/Ib) and high PRA (group II) (P < 0.0001).
    • No significant difference in newborn phenylalanine levels was found between groups Ia and Ib.
    • Patients in group II (higher PRA) demonstrated a significantly higher mean IQ at age 9 compared to groups Ia and Ib (P < 0.040).

    Conclusions:

    • Genotyping of the PAH gene provides valuable insights into predicted residual activity (PRA).
    • PRA is a significant factor in determining newborn phenylalanine levels and long-term intellectual outcomes in PKU.
    • Genotyping can aid in risk assessment for brain damage and guide personalized PKU management strategies.